GORDON CARL L — SEC insider filings

SEC reporting owner CIK 1282930. 81 insider filings on record with FilingPulse; latest filed 2026-11-10.

Transaction summary — filings shown

Covers the 50 most recent of 81 filings on record, filed 2022-06-21 to 2026-11-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Electra Therapeutics, Inc. (ETRA)Director, 10% owner318 legs · 1,898,020 sh · $24,349,642—8
ADARx Pharmaceuticals, Inc. (ADRX)Director, 10% owner23 legs · 950,000 sh · $16,150,000—16
Scribe Therapeutics, Inc. (SCTX)Director21 leg · 1,000,000 sh · $15,000,000—3
MBX Biosciences, Inc. (MBX)Director, 10% owner36 legs · 940,672 sh · $14,020,756—6
Keros Therapeutics, Inc. (KROS)Director5—2 legs · 250,000 sh · $11,002,5006
Terns Pharmaceuticals, Inc. (TERN)Director, 10% owner74 legs · 3,827,931 sh · $9,929,8006 legs · 56,164 sh · $561,6407
BlossomHill Therapeutics, Inc. (BLSM)Director21 leg · 625,000 sh · $10,000,000—5
Adicet Bio, Inc. (ACET)Director, 10% owner67 legs · 4,000,000 sh · $9,328,750—20
ArriVent Biopharma, Inc. (AVBP)Director, 10% owner12 legs · 444,444 sh · $7,999,992—8
Kinnate Biopharma Inc. (KNTE)Director, 10% owner514 legs · 2,866,100 sh · $7,760,135—11

+4 more issuers among the filings shown — every filing appears in the table below.

Insider filings — GORDON CARL L

FiledFormIssuerReported transactionsSource
2026-11-104Electra Therapeutics, Inc. (ETRA)Purchase (P): 9,816 @ $7.85 · Purchase (P): 39,600 @ $7.85 · Purchase (P): 4,000 @ $8.24 · Purchase (P): 16,000 @ $8.24 · Purchase (P): 20,700 @ $8.45 · Purchase (P): 2,000 @ $8.45EDGAR
2026-11-054Electra Therapeutics, Inc. (ETRA)Purchase (P): 24,313 @ $7.84 · Purchase (P): 97,800 @ $7.84 · Purchase (P): 24,400 @ $7.88 · Purchase (P): 98,600 @ $7.88 · Purchase (P): 9,267 @ $7.78 · Purchase (P): 37,100 @ $7.78 · +4 moreEDGAR
2026-09-304ADARx Pharmaceuticals, Inc. (ADRX)Conversion (C): 10,690,530 · Conversion (C): 2,000,962 · Conversion (C): 769,601 · Conversion (C): 564,187 · Purchase (P): 300,249 @ $17 · Conversion (C): 7,127,019 · +13 moreEDGAR
2026-09-243ADARx Pharmaceuticals, Inc. (ADRX)Holdings only — no transactions reportedEDGAR
2026-09-234Electra Therapeutics, Inc. (ETRA)Conversion (C): 2,002,310 · Conversion (C): 1,087,934 · Conversion (C): 1,703,314 · Purchase (P): 333,333 @ $15 · Conversion (C): 758,279 · Purchase (P): 1,000,000 @ $15 · +4 moreEDGAR
2026-08-124BlossomHill Therapeutics, Inc. (BLSM)Conversion (C): 1,039,996 · Conversion (C): 1,049,283 · Purchase (P): 625,000 @ $16 · Conversion (C): 1,039,996 (derivative) @ $0 · Conversion (C): 1,049,283 (derivative) @ $0EDGAR
2026-08-104BlossomHill Therapeutics, Inc. (BLSM)Grant/award (A): 23,904 (derivative) @ $0EDGAR
2026-07-294Scribe Therapeutics, Inc. (SCTX)Conversion (C): 348,825 · Purchase (P): 1,000,000 @ $15 · Conversion (C): 2,065,672 (derivative) @ $0EDGAR
2026-07-274Scribe Therapeutics, Inc. (SCTX)Grant/award (A): 14,725 (derivative) @ $0EDGAR
2026-01-054Compass Therapeutics, Inc. (CMPX)Grant/award (A): 90,000 (derivative) @ $0EDGAR
2025-12-184Keros Therapeutics, Inc. (KROS)Disposition to issuer (D): 140,057 @ $17.75 · Disposition to issuer (D): 74,465 @ $17.75EDGAR
2025-06-064Keros Therapeutics, Inc. (KROS)Grant/award (A): 5,250 @ $0 · Grant/award (A): 10,500 (derivative) @ $0EDGAR
2025-04-114Compass Therapeutics, Inc. (CMPX)Sale (S): 3,571,428 @ $1.59EDGAR
2025-02-194MBX Biosciences, Inc. (MBX)Purchase (P): 17,962 @ $9.90 · Purchase (P): 29,540 @ $9.85 · Purchase (P): 49,070 @ $10.84 · Purchase (P): 94,100 @ $10.84EDGAR
2025-02-134Compass Therapeutics, Inc. (CMPX)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2024-11-054Lomond Therapeutics Holdings, Inc.Conversion (C): 323,916 @ $3.20 · Conversion (C): 215,146 @ $3.20 · Conversion (C): 389,078 @ $3.60 · Conversion (C): 230,753 @ $3.60 · Conversion (C): 74,613 @ $3.60 · Grant/award (A): 808,894 @ $4 · +7 moreEDGAR
2024-09-174MBX Biosciences, Inc. (MBX)Conversion (C): 2,658,428 · Conversion (C): 403,787 · Purchase (P): 500,000 @ $16 · Purchase (P): 250,000 @ $16 · Conversion (C): 12,372,634 (derivative) · Conversion (C): 19,587,284 (derivative) · +1 moreEDGAR
2024-09-134MBX Biosciences, Inc. (MBX)Grant/award (A): 15,963 (derivative) @ $0EDGAR
2024-08-234Adicet Bio, Inc. (ACET)Disposition to issuer (D): 30,000 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0 · Disposition to issuer (D): 18,500 (derivative) @ $0 · Grant/award (A): 18,500 (derivative) @ $0 · Disposition to issuer (D): 18,500 (derivative) @ $0 · Grant/award (A): 18,500 (derivative) @ $0 · +2 moreEDGAR
2024-08-154Keros Therapeutics, Inc. (KROS)Sale (S): 220,600 @ $44.01 · Sale (S): 29,400 @ $44.01EDGAR
2024-07-174Terns Pharmaceuticals, Inc. (TERN)Sale (S): 39,433 @ $10 · Sale (S): 5,401 @ $10 · Sale (S): 6,142 @ $10 · Sale (S): 4,009 @ $10 · Sale (S): 556 @ $10 · Sale (S): 623 @ $10EDGAR
2024-07-024Terns Pharmaceuticals, Inc. (TERN)Grant/award (A): 4,676 (derivative) @ $0EDGAR
2024-06-144Terns Pharmaceuticals, Inc. (TERN)Grant/award (A): 32,000 (derivative) @ $0EDGAR
2024-06-074Adicet Bio, Inc. (ACET)Grant/award (A): 5,900 @ $0 · Grant/award (A): 26,400 (derivative) @ $0EDGAR
2024-06-034Keros Therapeutics, Inc. (KROS)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2024-05-204BiomX Inc. (PHGE)
jointly with OrbiMed Israel BioFund GP Limited Partnership, OrbiMed Israel GP Ltd., Chimovits Erez
Option exercise/expiry (X): 9,280,408 @ $0.24 · Sale (S): 24,344 @ $0.38 · Option exercise/expiry (X): 9,280,408 (derivative) @ $0EDGAR
2024-04-054Kinnate Biopharma Inc. (KNTE)Disposition to issuer (D): 1,368,339 · Disposition to issuer (D): 4,738,453 · Disposition to issuer (D): 1,368,338 · Disposition to issuer (D): 84,599 · Disposition to issuer (D): 450,000 · Disposition to issuer (D): 40,501 (derivative) · +2 moreEDGAR
2024-03-194BiomX Inc. (PHGE)
jointly with OrbiMed Israel BioFund GP Limited Partnership, OrbiMed Israel GP Ltd., Chimovits Erez
Purchase (P): 4,327 (derivative) · Purchase (P): 2,163,500 (derivative)EDGAR
2024-02-144Theseus Pharmaceuticals, Inc. (THRX)Code (U): 17,063,000 · Code (U): 650,600 · Disposition to issuer (D): 3,250 (derivative)EDGAR
2024-02-144Compass Therapeutics, Inc. (CMPX)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2024-01-314ArriVent Biopharma, Inc. (AVBP)Conversion (C): 821,827 · Conversion (C): 821,827 · Conversion (C): 469,615 · Conversion (C): 469,615 · Purchase (P): 222,222 @ $18 · Purchase (P): 222,222 @ $18 · +4 moreEDGAR
2024-01-264Adicet Bio, Inc. (ACET)Purchase (P): 1,841,100 @ $2.40 · Purchase (P): 242,200 @ $2.40 · Purchase (P): 1,041,700 @ $2.40EDGAR
2023-08-164Adicet Bio, Inc. (ACET)Disposition to issuer (D): 30,000 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0 · Disposition to issuer (D): 18,500 (derivative) @ $0 · Grant/award (A): 18,500 (derivative) @ $0 · Disposition to issuer (D): 18,500 (derivative) @ $0 · Grant/award (A): 18,500 (derivative) @ $0 · +2 moreEDGAR
2023-07-194Theseus Pharmaceuticals, Inc. (THRX)Purchase (P): 328,482 @ $3.05 · Purchase (P): 151,450 @ $3.05EDGAR
2023-06-294Adicet Bio, Inc. (ACET)Purchase (P): 125,000 @ $2.09 · Purchase (P): 250,000 @ $2.09 · Purchase (P): 442,000 @ $2.09 · Purchase (P): 58,000 @ $2.09EDGAR
2023-06-144Terns Pharmaceuticals, Inc. (TERN)Grant/award (A): 32,000 (derivative) @ $0EDGAR
2023-06-134Kinnate Biopharma Inc. (KNTE)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2023-06-134Theseus Pharmaceuticals, Inc. (THRX)Grant/award (A): 19,500 (derivative) @ $0 · Grant/award (A): 3,250 (derivative) @ $0EDGAR
2023-06-084Keros Therapeutics, Inc. (KROS)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2023-06-024Adicet Bio, Inc. (ACET)Grant/award (A): 5,900 @ $0 · Grant/award (A): 26,400 (derivative) @ $0EDGAR
2023-05-084Kinnate Biopharma Inc. (KNTE)Purchase (P): 83,459 @ $2.75 · Purchase (P): 312,991 @ $2.75 · Purchase (P): 83,459 @ $2.75 · Purchase (P): 490,512 @ $2.82 · Purchase (P): 490,511 @ $2.82EDGAR
2023-05-024Kinnate Biopharma Inc. (KNTE)Purchase (P): 60,998 @ $2.55 · Purchase (P): 228,754 @ $2.55 · Purchase (P): 60,997 @ $2.55 · Purchase (P): 124,544 @ $2.62 · Purchase (P): 467,068 @ $2.62 · Purchase (P): 124,545 @ $2.62 · +3 moreEDGAR
2023-03-174BiomX Inc. (PHGE)
jointly with OrbiMed Israel BioFund GP Limited Partnership, OrbiMed Israel GP Ltd., Chimovits Erez
Purchase (P): 348,000 @ $0.24 · Purchase (P): 1,789,959 (derivative)EDGAR
2023-02-224Kinnate Biopharma Inc. (KNTE)Grant/award (A): 550,000 · Grant/award (A): 550,000EDGAR
2023-02-094Compass Therapeutics, Inc. (CMPX)Grant/award (A): 60,000 (derivative) @ $0EDGAR
2022-12-284Terns Pharmaceuticals, Inc. (TERN)Purchase (P): 137,931 @ $7.25EDGAR
2022-11-104Compass Therapeutics, Inc. (CMPX)Purchase (P): 402,000 @ $3.21EDGAR
2022-11-094Theseus Pharmaceuticals, Inc. (THRX)Purchase (P): 192,000 @ $5.21EDGAR
2022-08-184Terns Pharmaceuticals, Inc. (TERN)Purchase (P): 2,470,200 @ $2.42 · Purchase (P): 457,400 @ $2.42 · Purchase (P): 762,400 @ $2.42 · Purchase (P): 207,500 (derivative) · Purchase (P): 38,450 (derivative) · Purchase (P): 64,050 (derivative)EDGAR
2022-06-214Terns Pharmaceuticals, Inc. (TERN)Grant/award (A): 32,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-16 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1282930 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs